Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Anatara Lifesciences Ltd ( (AU:ANR) ) has provided an announcement.
Anatara Lifesciences Ltd announced the issuance of 4,000,000 unquoted equity securities in the form of options expiring on November 26, 2028, with an exercise price of $0.025. This move is part of previously announced transactions and reflects the company’s ongoing efforts to strengthen its financial position and support its strategic initiatives, potentially impacting its market presence and stakeholder interests.
More about Anatara Lifesciences Ltd
Anatara Lifesciences Ltd operates in the biotechnology industry, focusing on developing solutions for gastrointestinal health. The company is engaged in creating innovative products that address unmet medical needs in both human and animal health markets.
Average Trading Volume: 3,398,674
Technical Sentiment Signal: Sell
Current Market Cap: A$2.97M
Find detailed analytics on ANR stock on TipRanks’ Stock Analysis page.